{"id":"NCT01468233","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa","officialTitle":"A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER II","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2014-04","completion":"2014-04","firstPosted":"2011-11-09","resultsPosted":"2015-10-28","lastUpdate":"2021-07-12"},"enrollment":326,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hidradenitis Suppurativa (HS)"],"interventions":[{"type":"BIOLOGICAL","name":"adalimumab","otherNames":["Humira"]},{"type":"BIOLOGICAL","name":"placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Adalimumab Every Week (EW)","type":"EXPERIMENTAL"},{"label":"Placebo/Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Adalimumab Every Week (EW)/Placebo","type":"EXPERIMENTAL"},{"label":"Adalimumab Every Week (EW)/ Adalimumab Every Other Week (EOW)","type":"EXPERIMENTAL"},{"label":"Adalimumab Every Week (EW)/Adalimumab Every Week (EW)","type":"EXPERIMENTAL"}],"summary":"A study to evaluate the safety and efficacy of treatment with adalimumab in adults with moderate to severe hidradenitis suppurativa (HS).","primaryOutcome":{"measure":"Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12","timeFrame":"Baseline (Week 0) up to Week 12","effectByArm":[{"arm":"Placebo","deltaMin":27.6,"sd":null},{"arm":"Adalimumab Every Week (EW)","deltaMin":58.9,"sd":null},{"arm":"Placebo - Baseline Hurley Stage II","deltaMin":36.8,"sd":null},{"arm":"Placebo - Baseline Hurley Stage III","deltaMin":17.1,"sd":null},{"arm":"Adalimumab Every Week (EW) - Baseline Hurley Stage II","deltaMin":62.4,"sd":null},{"arm":"Adalimumab Every Week (EW) - Baseline Hurley Stage III","deltaMin":55.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG002 vs OG004","p":"<0.001"},{"comp":"OG003 vs OG005","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["27518661","39141589","29380251"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":163},"commonTop":["HIDRADENITIS","HEADACHE","UPPER RESPIRATORY TRACT INFECTION","NASOPHARYNGITIS","DIARRHOEA"]}}